Last Updated: May 14, 2026

Patent: 10,259,837


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,259,837
Title:Method of separating rhamnolipids from a fermentation broth
Abstract:A method of extracting at least one rhamnolipid compound from a rhamnolipid fermentation mixture, the method comprising the steps of: (a) admixing an inert adsorbing support with a rhamnolipid fermentation mixture; (b) dissolving the mixture in an organic solvent at a temperature higher than 31° C. and at a pressure higher than 73 bars; (c) separating at least one fatty compound; (d) adding a co-solvent to said organic solvent; (e) modifying temperature and/or pressure; (f) separating a first rhamnolipid compound; and (g) separating a second rhamnolipid compound.
Inventor(s):Raymond John Marriott, Paul Simon Stevenson
Assignee: Conopco Inc
Application Number:US15/552,661
Patent Claims:see list of patent claims

Details for Patent 10,259,837

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Takeda Pharmaceuticals U.s.a., Inc. ADYNOVATE antihemophilic factor (recombinant), pegylated For Injection 125566 November 13, 2015 10,259,837 2036-02-25
Takeda Pharmaceuticals U.s.a., Inc. ADYNOVATE antihemophilic factor (recombinant), pegylated For Injection 125566 October 25, 2016 10,259,837 2036-02-25
Takeda Pharmaceuticals U.s.a., Inc. ADYNOVATE antihemophilic factor (recombinant), pegylated For Injection 125566 March 13, 2017 10,259,837 2036-02-25
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

International Patent Family for US Patent 10,259,837

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 2016139127 ⤷  Start Trial
United States of America 2018044364 ⤷  Start Trial
Turkey 201906421 ⤷  Start Trial
Mexico 384825 ⤷  Start Trial
Mexico 2017010507 ⤷  Start Trial
European Patent Office 3265576 ⤷  Start Trial
China 107405537 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.